JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1099231, encodeId=d6ca10992313b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099232, encodeId=9fd21099232d5, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589260, encodeId=3b1a58926005, content=投稿状态使Out for Review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aefc1957582, createdName=Sichuan University, createdTime=Sun Apr 19 16:29:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853700, encodeId=686e853e00cb, content=审稿速度很快，一审返意见不到一个月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Wed Sep 11 12:55:40 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567010, encodeId=e50356e010a3, content=你好，这杂志要版面费吗？梅斯app里面是非OA，官网明确是开源的～木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, beContent=木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544632, encodeId=403b54463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请教： 做水解酶和其抑制蛋白的作用属于该杂志的范围吗？ 该酶和医学扯不上关系， 普通的水解酶，工业上用的较多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Thu Jul 20 08:09:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831564, encodeId=5c3d8315647b, content=审稿速度:1.0 经验分享：我们投稿后很快收到修改意见，但修改稿的审阅偏慢，经过电邮询问后，告知接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Sat Jan 23 12:00:45 CST 2016, time=2016-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504589, encodeId=e2e9504589d6, content=惊喜，去年只有1分多一点，今年一下子到2分多，不过上3分，就相当于过门槛了，接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

和讨论比，引言撰写的方式有什么不同？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099231, encodeId=d6ca10992313b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099232, encodeId=9fd21099232d5, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589260, encodeId=3b1a58926005, content=投稿状态使Out for Review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aefc1957582, createdName=Sichuan University, createdTime=Sun Apr 19 16:29:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853700, encodeId=686e853e00cb, content=审稿速度很快，一审返意见不到一个月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Wed Sep 11 12:55:40 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567010, encodeId=e50356e010a3, content=你好，这杂志要版面费吗？梅斯app里面是非OA，官网明确是开源的～木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, beContent=木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544632, encodeId=403b54463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请教： 做水解酶和其抑制蛋白的作用属于该杂志的范围吗？ 该酶和医学扯不上关系， 普通的水解酶，工业上用的较多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Thu Jul 20 08:09:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831564, encodeId=5c3d8315647b, content=审稿速度:1.0 经验分享：我们投稿后很快收到修改意见，但修改稿的审阅偏慢，经过电邮询问后，告知接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Sat Jan 23 12:00:45 CST 2016, time=2016-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504589, encodeId=e2e9504589d6, content=惊喜，去年只有1分多一点，今年一下子到2分多，不过上3分，就相当于过门槛了，接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

引言一般是三段式么？

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099231, encodeId=d6ca10992313b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099232, encodeId=9fd21099232d5, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589260, encodeId=3b1a58926005, content=投稿状态使Out for Review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aefc1957582, createdName=Sichuan University, createdTime=Sun Apr 19 16:29:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853700, encodeId=686e853e00cb, content=审稿速度很快，一审返意见不到一个月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Wed Sep 11 12:55:40 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567010, encodeId=e50356e010a3, content=你好，这杂志要版面费吗？梅斯app里面是非OA，官网明确是开源的～木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, beContent=木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544632, encodeId=403b54463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请教： 做水解酶和其抑制蛋白的作用属于该杂志的范围吗？ 该酶和医学扯不上关系， 普通的水解酶，工业上用的较多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Thu Jul 20 08:09:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831564, encodeId=5c3d8315647b, content=审稿速度:1.0 经验分享：我们投稿后很快收到修改意见，但修改稿的审阅偏慢，经过电邮询问后，告知接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Sat Jan 23 12:00:45 CST 2016, time=2016-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504589, encodeId=e2e9504589d6, content=惊喜，去年只有1分多一点，今年一下子到2分多，不过上3分，就相当于过门槛了，接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2020-04-19 Sichuan University

投稿状态使Out for Review会持续多久？

117 0

[GetPortalCommentsPageByObjectIdResponse(id=1099231, encodeId=d6ca10992313b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099232, encodeId=9fd21099232d5, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589260, encodeId=3b1a58926005, content=投稿状态使Out for Review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aefc1957582, createdName=Sichuan University, createdTime=Sun Apr 19 16:29:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853700, encodeId=686e853e00cb, content=审稿速度很快，一审返意见不到一个月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Wed Sep 11 12:55:40 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567010, encodeId=e50356e010a3, content=你好，这杂志要版面费吗？梅斯app里面是非OA，官网明确是开源的～木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, beContent=木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544632, encodeId=403b54463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请教： 做水解酶和其抑制蛋白的作用属于该杂志的范围吗？ 该酶和医学扯不上关系， 普通的水解酶，工业上用的较多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Thu Jul 20 08:09:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831564, encodeId=5c3d8315647b, content=审稿速度:1.0 经验分享：我们投稿后很快收到修改意见，但修改稿的审阅偏慢，经过电邮询问后，告知接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Sat Jan 23 12:00:45 CST 2016, time=2016-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504589, encodeId=e2e9504589d6, content=惊喜，去年只有1分多一点，今年一下子到2分多，不过上3分，就相当于过门槛了，接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2019-09-11 ms6967342940128728

审稿速度很快，一审返意见不到一个月

112 0

[GetPortalCommentsPageByObjectIdResponse(id=1099231, encodeId=d6ca10992313b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099232, encodeId=9fd21099232d5, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589260, encodeId=3b1a58926005, content=投稿状态使Out for Review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aefc1957582, createdName=Sichuan University, createdTime=Sun Apr 19 16:29:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853700, encodeId=686e853e00cb, content=审稿速度很快，一审返意见不到一个月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Wed Sep 11 12:55:40 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567010, encodeId=e50356e010a3, content=你好，这杂志要版面费吗？梅斯app里面是非OA，官网明确是开源的～木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, beContent=木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544632, encodeId=403b54463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请教： 做水解酶和其抑制蛋白的作用属于该杂志的范围吗？ 该酶和医学扯不上关系， 普通的水解酶，工业上用的较多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Thu Jul 20 08:09:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831564, encodeId=5c3d8315647b, content=审稿速度:1.0 经验分享：我们投稿后很快收到修改意见，但修改稿的审阅偏慢，经过电邮询问后，告知接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Sat Jan 23 12:00:45 CST 2016, time=2016-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504589, encodeId=e2e9504589d6, content=惊喜，去年只有1分多一点，今年一下子到2分多，不过上3分，就相当于过门槛了，接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2019-02-20 千军独木

你好，这杂志要版面费吗？梅斯app里面是非OA，官网明确是开源的～木子美玟007 2018-03-15 00:00:00 发表:
版面费贵吗

木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗

198 0

[GetPortalCommentsPageByObjectIdResponse(id=1099231, encodeId=d6ca10992313b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099232, encodeId=9fd21099232d5, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589260, encodeId=3b1a58926005, content=投稿状态使Out for Review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aefc1957582, createdName=Sichuan University, createdTime=Sun Apr 19 16:29:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853700, encodeId=686e853e00cb, content=审稿速度很快，一审返意见不到一个月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Wed Sep 11 12:55:40 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567010, encodeId=e50356e010a3, content=你好，这杂志要版面费吗？梅斯app里面是非OA，官网明确是开源的～木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, beContent=木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544632, encodeId=403b54463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请教： 做水解酶和其抑制蛋白的作用属于该杂志的范围吗？ 该酶和医学扯不上关系， 普通的水解酶，工业上用的较多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Thu Jul 20 08:09:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831564, encodeId=5c3d8315647b, content=审稿速度:1.0 经验分享：我们投稿后很快收到修改意见，但修改稿的审阅偏慢，经过电邮询问后，告知接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Sat Jan 23 12:00:45 CST 2016, time=2016-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504589, encodeId=e2e9504589d6, content=惊喜，去年只有1分多一点，今年一下子到2分多，不过上3分，就相当于过门槛了，接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2017-07-20 tonycjlu

审稿速度:3.0 | 投稿命中率:50.0
经验分享：请教：
做水解酶和其抑制蛋白的作用属于该杂志的范围吗？

该酶和医学扯不上关系，

普通的水解酶，工业上用的较多。

375 0

[GetPortalCommentsPageByObjectIdResponse(id=1099231, encodeId=d6ca10992313b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099232, encodeId=9fd21099232d5, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589260, encodeId=3b1a58926005, content=投稿状态使Out for Review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aefc1957582, createdName=Sichuan University, createdTime=Sun Apr 19 16:29:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853700, encodeId=686e853e00cb, content=审稿速度很快，一审返意见不到一个月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Wed Sep 11 12:55:40 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567010, encodeId=e50356e010a3, content=你好，这杂志要版面费吗？梅斯app里面是非OA，官网明确是开源的～木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, beContent=木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544632, encodeId=403b54463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请教： 做水解酶和其抑制蛋白的作用属于该杂志的范围吗？ 该酶和医学扯不上关系， 普通的水解酶，工业上用的较多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Thu Jul 20 08:09:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831564, encodeId=5c3d8315647b, content=审稿速度:1.0 经验分享：我们投稿后很快收到修改意见，但修改稿的审阅偏慢，经过电邮询问后，告知接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Sat Jan 23 12:00:45 CST 2016, time=2016-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504589, encodeId=e2e9504589d6, content=惊喜，去年只有1分多一点，今年一下子到2分多，不过上3分，就相当于过门槛了，接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2016-01-23 ms9051856686409430

审稿速度:1.0
经验分享：我们投稿后很快收到修改意见，但修改稿的审阅偏慢，经过电邮询问后，告知接受。

108 0

[GetPortalCommentsPageByObjectIdResponse(id=1099231, encodeId=d6ca10992313b, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099232, encodeId=9fd21099232d5, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589260, encodeId=3b1a58926005, content=投稿状态使Out for Review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aefc1957582, createdName=Sichuan University, createdTime=Sun Apr 19 16:29:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853700, encodeId=686e853e00cb, content=审稿速度很快，一审返意见不到一个月 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ef5414095, createdName=ms6967342940128728, createdTime=Wed Sep 11 12:55:40 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567010, encodeId=e50356e010a3, content=你好，这杂志要版面费吗？梅斯app里面是非OA，官网明确是开源的～木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, beContent=木子美玟007 2018-03-15 00:00:00 发表: 版面费贵吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Wed Feb 20 00:00:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544632, encodeId=403b54463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请教： 做水解酶和其抑制蛋白的作用属于该杂志的范围吗？ 该酶和医学扯不上关系， 普通的水解酶，工业上用的较多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d7194947, createdName=tonycjlu, createdTime=Thu Jul 20 08:09:00 CST 2017, time=2017-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831564, encodeId=5c3d8315647b, content=审稿速度:1.0 经验分享：我们投稿后很快收到修改意见，但修改稿的审阅偏慢，经过电邮询问后，告知接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Sat Jan 23 12:00:45 CST 2016, time=2016-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504589, encodeId=e2e9504589d6, content=惊喜，去年只有1分多一点，今年一下子到2分多，不过上3分，就相当于过门槛了，接下为就容易了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhiqi, createdTime=Wed Jul 30 13:20:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2014-07-30 zhiqi

惊喜，去年只有1分多一点，今年一下子到2分多，不过上3分，就相当于过门槛了，接下为就容易了

386 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务